CHEO Genetics Diagnostic Laboratory (Children's Hospital of Eastern Ontario)
General information
CHEO Genetics Diagnostic Laboratory
Children's Hospital of Eastern Ontario
401 Smyth Road
Ottawa
Ontario
Canada - K1H 8L1
https://www.cheo.on.ca/en/clinics-services-programs/genetics-diagnostic-laboratory.aspx
Organization ID: 1050
Children's Hospital of Eastern Ontario
401 Smyth Road
Ottawa
Ontario
Canada - K1H 8L1
https://www.cheo.on.ca/en/clinics-services-programs/genetics-diagnostic-laboratory.aspx
Organization ID: 1050
Personnel
- Mahdi Ghani, Contact
Phone: 16137377600
Email: mghani@cheo.on.ca - Mahdi Ghani, Contact
Phone: 16137377600
Email: mghani@cheo.on.ca - Olga Jarinova
Phone: (613) 737-7600
Email: ojarinova@cheo.on.ca
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 8383
Gene
Gene | Submissions | Last Updated |
---|---|---|
ABCC9 | 63 | Mar 9, 2023 |
ACTA2 | 19 | Jan 31, 2024 |
ACTA2-AS1 | 7 | Jan 31, 2024 |
ACTC1 | 37 | Jan 31, 2024 |
ACTN2 | 116 | Jan 31, 2024 |
ANKRD1 | 15 | Dec 23, 2021 |
ARIH1 | 3 | Jan 30, 2024 |
ATM | 262 | May 3, 2024 |
BAG3 | 23 | Jan 31, 2024 |
BARD1 | 31 | Jan 30, 2024 |
BRCA1 | 219 | Jan 31, 2024 |
BRCA2 | 421 | Jan 31, 2024 |
BRIP1 | 79 | Jan 31, 2024 |
C11orf65 | 92 | May 3, 2024 |
C2orf49 | 10 | Mar 3, 2020 |
CASQ2 | 30 | Mar 9, 2023 |
CAV3 | 25 | Dec 23, 2021 |
CDH1 | 75 | Jan 31, 2024 |
CEP85L | 11 | Jan 31, 2024 |
CHEK2 | 65 | Jan 31, 2024 |
COL3A1 | 82 | Jan 31, 2024 |
CRYAB | 7 | Mar 3, 2020 |
CSRP3 | 40 | Aug 2, 2024 |
CSRP3-AS1 | 1 | Apr 30, 2018 |
CTF1 | 12 | Mar 9, 2023 |
DES | 40 | Jan 31, 2024 |
DNAAF3 | 2 | Mar 3, 2020 |
DNASE1L1 | 1 | Apr 30, 2018 |
DSC2 | 61 | Jan 31, 2024 |
DSCAS | 4 | Dec 23, 2021 |
DSG2 | 87 | Jan 31, 2024 |
DSG2-AS1 | 39 | Jan 31, 2024 |
DSP | 169 | Oct 25, 2024 |
DSP-AS1 | 4 | Mar 9, 2023 |
EFEMP2 | 8 | Jan 30, 2024 |
EMD | 13 | Mar 9, 2023 |
FBN1 | 323 | Oct 2, 2024 |
FHL2 | 15 | Mar 3, 2020 |
FLNC | 119 | Jan 31, 2024 |
FLNC-AS1 | 43 | Jan 30, 2024 |
FOXE3 | 8 | Jan 30, 2024 |
GJD2-DT | 37 | Jan 31, 2024 |
GLA | 22 | Jan 31, 2024 |
HOXB13 | 1 | Jan 30, 2024 |
JUP | 51 | Jan 31, 2024 |
LAMA4 | 71 | Mar 9, 2023 |
LAMA4-AS1 | 1 | Mar 9, 2023 |
LAMP2 | 23 | Jan 31, 2024 |
LDB3 | 73 | Oct 25, 2024 |
LINC01389 | 8 | Jan 30, 2024 |
LMNA | 60 | Oct 2, 2024 |
LOC101927055 | 33 | Jan 30, 2024 |
LOC110121269 | 9 | Jan 30, 2024 |
LOC110121486 | 4 | Oct 25, 2024 |
LOC113939944 | 9 | Jan 31, 2024 |
LOC114827850 | 8 | Mar 9, 2023 |
LOC114827851 | 18 | Dec 23, 2021 |
LOC126805765 | 7 | Mar 9, 2023 |
LOC126805877 | 6 | Jan 30, 2024 |
LOC126806067 | 4 | Dec 23, 2021 |
LOC126806068 | 7 | Dec 23, 2021 |
LOC126806420 | 12 | Jan 31, 2024 |
LOC126806421 | 15 | Jan 31, 2024 |
LOC126806422 | 25 | Jan 31, 2024 |
LOC126806423 | 19 | Jan 31, 2024 |
LOC126806424 | 21 | Jan 31, 2024 |
LOC126806425 | 18 | Jan 31, 2024 |
LOC126806426 | 10 | Jan 30, 2024 |
LOC126806427 | 18 | Jan 31, 2024 |
LOC126806428 | 12 | Jan 30, 2024 |
LOC126806429 | 9 | Jan 31, 2024 |
LOC126806430 | 21 | Jan 31, 2024 |
LOC126806431 | 19 | Jan 31, 2024 |
LOC126806433 | 13 | Mar 9, 2023 |
LOC126806446 | 1 | Mar 3, 2020 |
LOC126806791 | 5 | Mar 9, 2023 |
LOC126806792 | 1 | Dec 23, 2021 |
LOC126859766 | 5 | Mar 3, 2020 |
LOC126860794 | 4 | Mar 9, 2023 |
LOC126861896 | 11 | Mar 9, 2023 |
LOC126861897 | 38 | Jan 31, 2024 |
LOC126861898 | 38 | Jan 31, 2024 |
LOC126862124 | 7 | Jan 31, 2024 |
LOC126862571 | 28 | Jan 31, 2024 |
LOC129390903 | 4 | Jan 31, 2024 |
LOC129931597 | 3 | Dec 23, 2021 |
LOC129935182 | 3 | Mar 9, 2023 |
LOC129935183 | 6 | Jan 31, 2024 |
LOC129935184 | 2 | Jan 31, 2024 |
LOC129999273 | 3 | Jan 31, 2024 |
LOC129999660 | 8 | Jan 31, 2024 |
LOC130002223 | 2 | Apr 30, 2018 |
LOC130003020 | 1 | Jan 31, 2024 |
LOC130004109 | 5 | Dec 23, 2021 |
LOC130004243 | 1 | Apr 30, 2018 |
LOC130057019 | 2 | Jan 31, 2024 |
LOC130057352 | 1 | Dec 23, 2021 |
LOC130058878 | 8 | Mar 9, 2023 |
LOC130061310 | 1 | Mar 9, 2023 |
LOC130062340 | 3 | Jan 30, 2024 |
LOC130062899 | 5 | Jan 30, 2024 |
LOX | 10 | Jan 30, 2024 |
MHRT | 52 | Jan 31, 2024 |
MIR208B | 1 | Jan 30, 2024 |
MLH1 | 80 | Jan 31, 2024 |
MSH2 | 92 | Jan 31, 2024 |
MSH6 | 113 | Jan 31, 2024 |
MUS81 | 1 | Jan 30, 2024 |
MYBPC3 | 451 | Oct 25, 2024 |
MYH11 | 171 | Jan 31, 2024 |
MYH6 | 139 | Mar 9, 2023 |
MYH7 | 375 | Oct 25, 2024 |
MYL2 | 40 | Jan 31, 2024 |
MYL3 | 30 | Jan 31, 2024 |
MYLK | 138 | Jan 31, 2024 |
MYLK-AS1 | 14 | Jan 30, 2024 |
MYLK2 | 35 | Dec 23, 2021 |
MYOZ2 | 20 | Dec 23, 2021 |
NDE1 | 75 | Jan 31, 2024 |
NEXN | 86 | Jan 31, 2024 |
NOTCH1 | 224 | Jan 31, 2024 |
OXTR | 22 | Dec 23, 2021 |
PALB2 | 82 | Jan 31, 2024 |
PKP2 | 91 | Jan 31, 2024 |
PLN | 11 | Jan 31, 2024 |
PMS2 | 115 | Jan 31, 2024 |
PRKAG2 | 71 | Jan 31, 2024 |
PRKG1 | 9 | Jan 30, 2024 |
PTEN | 27 | Jan 31, 2024 |
RAD51C | 37 | Jan 31, 2024 |
RAD51D | 26 | Jan 31, 2024 |
RAD51L3-RFFL | 26 | Jan 31, 2024 |
RBM20 | 112 | Jan 31, 2024 |
ROBO4 | 34 | Jan 30, 2024 |
RPL36A-HNRNPH2 | 22 | Jan 31, 2024 |
RYR2 | 169 | Mar 9, 2023 |
SCN5A | 61 | Jan 30, 2024 |
SGCD | 11 | Dec 23, 2021 |
SLC2A10 | 45 | Jan 31, 2024 |
SMAD2 | 2 | Jan 30, 2024 |
SMAD3 | 47 | Jan 31, 2024 |
SMAD4 | 9 | Dec 23, 2021 |
SRFBP1 | 10 | Jan 30, 2024 |
SSUH2 | 3 | Dec 23, 2021 |
STK11 | 52 | Jan 31, 2024 |
TAFAZZIN | 6 | Apr 30, 2018 |
TCAP | 13 | Mar 9, 2023 |
TGFB2 | 27 | Jan 30, 2024 |
TGFB3 | 21 | Jan 31, 2024 |
TGFBR1 | 40 | Jan 31, 2024 |
TGFBR2 | 48 | Jan 31, 2024 |
THSD4 | 19 | Jan 30, 2024 |
TMEM43 | 27 | Jan 31, 2024 |
TNNC1 | 24 | Jan 30, 2024 |
TNNI3 | 52 | Sep 23, 2024 |
TNNT1 | 1 | Apr 30, 2018 |
TNNT2 | 77 | Jan 31, 2024 |
TP53 | 42 | Jan 31, 2024 |
TPM1 | 52 | Jan 31, 2024 |
TTN | 2058 | Jan 31, 2024 |
TTN-AS1 | 1229 | Jan 31, 2024 |
TTR | 28 | Jan 31, 2024 |
VANGL1 | 2 | Apr 30, 2018 |
VCL | 65 | Jan 31, 2024 |
Condition
Name | Submissions | Last Updated |
---|---|---|
Breast and/or ovarian cancer | 1802 | May 3, 2024 |
Breast-ovarian cancer, familial, susceptibility to, 1 | 1 | Mar 9, 2015 |
Cardiomyopathy | 5274 | Oct 25, 2024 |
Familial thoracic aortic aneurysm and aortic dissection | 1287 | Oct 2, 2024 |
Hereditary breast ovarian cancer syndrome | 10 | Dec 29, 2023 |
not provided | 1 | Aug 24, 2023 |
not specified | 8 | Aug 28, 2017 |
Testing in GTR
Disease name | Number of tests |
---|---|
Angelman syndrome | 1 test |
Arrhythmogenic right ventricular cardiomyopathy | 2 tests |
Arterial tortuosity syndrome | 2 tests |
Breast-ovarian cancer, familial, susceptibility to, 1 | 3 tests |
Breast-ovarian cancer, familial, susceptibility to, 2 | 3 tests |
Cardiomyopathy | 1 test |
Facioscapulohumeral muscular dystrophy | 1 test |
Familial pancreatic carcinoma | 1 test |
Fragile X syndrome | 1 test |
Hereditary breast ovarian cancer syndrome | 1 test |
Hereditary hemochromatosis | 1 test |
Hypertrophic cardiomyopathy | 2 tests |
Loeys-Dietz syndrome | 2 tests |
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections | 2 tests |
Marfan syndrome | 2 tests |
Myotonic dystrophy type 2 | 1 test |
Oculopharyngeal muscular dystrophy | 1 test |
Prader-Willi syndrome | 1 test |
Spinal muscular atrophy | 1 test |
Steinert myotonic dystrophy syndrome | 1 test |
Thrombophilia due to thrombin defect | 1 test |